Allergy and Immunology · San Antonio, TX
NPI
1700198165
Since 2010
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2424 Babcock Rd Ste 301
San Antonio, TX, 78229
Phone (210) 616-0882
Groups this clinician bills Medicare through
Medicare paid, 2024
$525K
20,374 services
Medicare patients, 2024
208
Average age 70
Drug cost, 2024
$862K
1,912 prescriptions
Company payments, 2025
$90K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lukena U Karkhanis was code J2357 (injection, omalizumab, 5 mg), 9,081 times for 26 patients. In total Lukena U Karkhanis billed 20,374 services in 35 codes, and Medicare paid $525K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 9,081 | 26 | $29.67 | $269K |
| 95004 Test - Miscellaneous | Office | 1,078 | 18 | $2.72 | $2,933 |
| 95165 Treatment - Miscellaneous | Office | 920 | 32 | $10.78 | $9,914 |
| 96401 Chemotherapy Administration | Office | 382 | 36 | $50.19 | $19K |
| 95117 Treatment - Miscellaneous | Office | 252 | 52 | $7.60 | $1,914 |
| 99214 Office E&M - Established | Office | 129 | 81 | $88.89 | $11K |
| 94010 Pulmonary Function Testing | Office | 96 | 62 | $20.03 | $1,923 |
| 94664 E&M - Miscellaneous | Office | 88 | 52 | $13.01 | $1,145 |
| 99213 Office E&M - Established | Office | 76 | 62 | $63.73 | $4,843 |
| 95115 Treatment - Miscellaneous | Office | 51 | 12 | $5.85 | $298 |
| 95012 Pulmonary | Office | 43 | 30 | $14.02 | $603 |
| 99204 Office E&M - New | Office | 26 | 26 | $120.30 | $3,128 |
| 94060 Pulmonary Function Testing | Office | 21 | 18 | $29.15 | $612 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 18 | 15 | $0.04 | $0.65 |
| 70486 CT/CTA - Head and Neck | Office | 16 | 16 | $88.36 | $1,414 |
By year: 2022 $273K for 11,282 services; 2023 $394K for 15,586 services; 2024 $525K for 20,374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lukena U Karkhanis prescribed most often to Medicare patients was Montelukast Sodium, with 236 prescriptions and refills. In total Lukena U Karkhanis wrote 1,912 Medicare prescriptions that cost $862K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 236 | 555 | 78 | $1,919 |
| Fluticasone Propionate Generic | 172 | 321 | 66 | $3,174 |
| Epinephrine Generic | 132 | 143 | 101 | $28K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 122 | 141 | 44 | $2,708 |
| Dupixent Syringe Dupilumab | 111 | 111 | 11 | $453K |
| Azelastine Hcl Generic | 94 | 216 | 49 | $4,494 |
| Famotidine Generic | 84 | 160 | 36 | $1,440 |
| Ipratropium Bromide Generic | 81 | 139 | 31 | $3,131 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 78 | 152 | 26 | $96K |
| Sodium Chloride 0.9 % Sodium Chloride | 60 | 60 | Under 11 | $608 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 43 | 85 | 15 | $52K |
| Symbicort Budesonide/Formoterol Fumarate | 42 | 76 | 17 | $16K |
| Omeprazole Generic | 36 | 83 | 16 | $745 |
| Prednisone Generic | 36 | 36 | 30 | $62.33 |
| Ondansetron Hcl Generic | 35 | 35 | Under 11 | $587 |
Brand drugs: - claims; generic drugs: 1,318 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lukena U Karkhanis $90K ($90K in general payments such as food, travel and fees) from 32 companies. The largest payer was Genzyme Corporation with $32K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 32 | $32K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 38 | $21K |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $11K |
| Novartis Pharmaceuticals Corporation NVS | 30 | $7,616 |
| CSL Behring CSL.AX | 24 | $6,588 |
| Grifols USA, LLC | 15 | $4,256 |
| Grifols Shared Services North America, Inc. | 1 | $1,710 |
| AstraZeneca Pharmaceuticals LP AZN | 31 | $1,031 |
| Galderma Laboratories, L.P. GALD.SW | 15 | $721 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 17 | $437 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.